Verum Partners’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$704K Buy
2,238
+411
+22% +$130K 0.11% 100
2026
Q1
$600K Buy
1,827
+1,096
+150% +$393K 0.11% 97
2025
Q4
$257K Sell
731
-3
-0.4% -$1.09K 0.05% 147
2025
Q3
$271K Buy
734
+1
+0.1% +$386 0.06% 143
2025
Q2
$290K Buy
733
+53
+8% +$19.8K 0.07% 136
2025
Q1
$253K Buy
680
+4
+0.6% +$1.52K 0.07% 137
2024
Q4
$243K Buy
676
+10
+2% +$3.71K 0.07% 141
2024
Q3
$241K Sell
666
-2
-0.3% -$690 0.07% 143
2024
Q2
$227K Sell
668
-37
-5% -$12.5K 0.07% 143
2024
Q1
$252K Buy
+705
New +$237K 0.09% 133
2023
Q3
Sell
-678
Closed -$207K 148
2023
Q2
$207K Buy
+678
New +$196K 0.19% 102

Other funds holding SYK

Verum Partners's SYK Position: Q2 2026 in Review

Verum Partners increased its Stryker (SYK) stake by 22% in Q2 2026, buying an estimated $130K and bringing the position to 2,238 shares worth $704K. The position accounts for 0.11% of the portfolio, ranked #100.

Verum Partners first reported a position in SYK in Q2 2023 and has held it in 11 quarters since. 568 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Verum Partners held 2,238 shares of Stryker worth $704K as of Q2 2026.
  • Verum Partners bought 411 Stryker shares in Q2 2026, an estimated $130K.
  • Stryker made up 0.11% of Verum Partners's portfolio in Q2 2026, its #100 holding.
  • Verum Partners first reported a position in Stryker in Q2 2023 and has held it in 11 quarters since.
  • 568 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Verum Partners's 13F filing for Q2 2026, filed 22 Jul 2026.